levodopa methyl ester has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domino, EF; Emborg-Knott, ME | 1 |
| Domino, EF; Ni, L | 1 |
2 other study(ies) available for levodopa methyl ester and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose.
Topics: Animals; Antiparkinson Agents; Carotid Arteries; Dopamine Agents; Drug Administration Schedule; Female; Follow-Up Studies; Infusions, Intra-Arterial; Levodopa; Macaca nemestrina; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Rotation | 1998 |
Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys.
Topics: Animals; Antiparkinson Agents; Chronic Disease; Dopamine Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; Levodopa; Macaca nemestrina; MPTP Poisoning; Parkinson Disease, Secondary; Treatment Outcome; Trihexyphenidyl | 1998 |